Medicamen Biotech's Staggering Q1 Loss: What Drove the Plunge and Can it Recover?

Medicamen Biotech just released its Q1 FY25 results, showing a stark swing from profit to …

Aug 16, 2025 16:26

Concord Biotech's Q1FY26 Dip: Is This Biopharma Stock a Hidden Gem or a Warning Sign?

Concord Biotech’s Q1FY26 results presented a puzzling dip in revenue and EBITDA. Is this cause …

Aug 16, 2025 15:50